Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update.
2020
Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an attractive therapeutic target for many cancers, especially for cancers driven by transcriptional dysregulation. I...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
131
References
15
Citations
NaN
KQI